CYCN earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.56. Updated 2026-07-23.
Cyclerion Therapeutics (CYCN) Research Hub
Cyclerion Therapeutics (CYCN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-08, shares last closed at 23.52 USD (-20.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.56, market cap 0.02B. This hub links to the full technical, earnings and options research available for CYCN.
Last updated 2026-09-08 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 23.52 USD (-20.94%) |
| 52-week range | 19.74 USD – 36.33 USD |
| Trend regime | Range |
| 14-day RSI | 48.2 (Neutral) |
| Trailing P/E | -2.56 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for CYCN
Covered Call on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
CYCN technical analysis: range, last 23.52 USD, RSI 48.2, 52w range 19.74 USD–36.33 USD, real support/resistance. Updated 2026-09-08.
Frequently asked questions
What sector is CYCN in?
Cyclerion Therapeutics (CYCN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CYCN in an uptrend or downtrend?
As of 2026-09-08, CYCN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CYCN's trailing P/E ratio?
CYCN's trailing P/E is -2.56, with a market cap of 0.02B. See the earnings research page for full valuation detail.